학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 373건 | 목록 1~10
Academic Journal
Durot E; Department of Hematology, University Hospital of Reims, Reims, France.; Roos-Weil D; Sorbonne Université, Hematology, Pitié-Salpêtrière Hospital, Paris, France.; Chauchet A; Department of Hematology, University Hospital of Besançon, Besançon, France.; Decroocq J; Department of Hematology, Hôpital Cochin, Paris, France.; Di Blasi R; Department of Hematology, Hôpital Saint Louis, Paris, France.; Gastinne T; Department of Hematology, University Hospital of Nantes, Nantes, France.; Bensaber H; Department of Hematology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.; Cheminant M; Department of Hematology, Hôpital Necker, Paris, France.; Jacquet C; Department of Hematology, University Hospital of Nancy, Nancy, France.; Guidez S; Department of Hematology, University Hospital of Poitiers, Poitiers, France.; Gros FX; Department of Hematology, University Hospital of de Bordeaux, Bordeaux, France.; Bachy E; Department of Hematology, Hospices Civils de Lyon, Pierre Bénite, Lyon, France.; Coste A; Department of Hematology, University Hospital of Reims, Reims, France.; Cony-Makhoul P; Medical and Scientific Department, Lymphoma Academic Research Organisation, Hôpital Lyon-Sud, Pierre-Bénite, France.; Treon SP; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Delmer A; Department of Hematology, University Hospital of Reims, Reims, France.; Reshef R; Division of Hematology/Oncology and Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY.; Le Gouill S; Department of Hematology, Institut Curie, Paris, France.; Castillo JJ; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Houot R; Department of Hematology, University Hospital of Rennes, Rennes, France.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Zanwar S; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.; Le-Rademacher J; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.; Durot E; Department of Hematology, University Hospital of Reims and UFR Médecine, Reims, France.; D'Sa S; University College of London, London, United Kingdom.; Abeykoon JP; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.; Mondello P; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.; Kumar S; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.; Sarosiek S; Dana-Farber Cancer Institute, Boston, MA.; Paludo J; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.; Chhabra S; Division of Hematology, Mayo Clinic, Scottsdale, AZ.; Cook JM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.; Parrondo R; Division of Hematology, Mayo Clinic, Jacksonville, FL.; Dispenzieri A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.; Gonsalves WI; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.; Muchtar E; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.; Ailawadhi S; Division of Hematology, Mayo Clinic, Jacksonville, FL.; Kyle RA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.; Rajkumar SV; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.; Delmer A; Department of Hematology, University Hospital of Reims and UFR Médecine, Reims, France.; Fonseca R; Division of Hematology, Mayo Clinic, Scottsdale, AZ.; Gertz MA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.; Treon SP; Dana-Farber Cancer Institute, Boston, MA.; Ansell SM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.; Castillo JJ; Dana-Farber Cancer Institute, Boston, MA.; Kapoor P; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Richardson K; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Castillo JJ; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Sarosiek SR; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Branagan AR; Department of Medicine, Harvard Medical School, Boston, MA.; MGH Cancer Center, Massachusetts General Hospital, Boston, MA.; Flynn CA; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA.; Meid K; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA.; Gustine JN; Department of Medicine, Harvard Medical School, Boston, MA.; MGH Cancer Center, Massachusetts General Hospital, Boston, MA.; Liu X; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Kofides A; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA.; Liu S; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Wolf JL; Wolf Biostatistics, Boston, MA.; Kacena KA; BioBridges, Boston, MA.; Patterson CJ; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA.; Guerrera ML; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Tsakmaklis N; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA.; Treon SP; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Hunter ZR; Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Treon SP; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Sarosiek S; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Castillo JJ; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Publisher: American Association of Immunologists Country of Publication: United States NLM ID: 2985117R Publication Model: Print Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Tam CS; Department of Haematology, Alfred Hospital and Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.; Opat S; Department of Haematology, Monash Health and Monash University, Clayton, VIC, Australia.; D'Sa S; Centre for Waldenström's Macroglobulinemia and Associated Disorders, University College London Hospital Foundation Trust, London, United Kingdom.; Jurczak W; Department of Clinical Oncology, Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland.; Lee HP; Department of Haematology, Flinders Medical Centre, Adelaide, SA, Australia.; Cull G; Department of Haematology, Sir Charles Gairdner Hospital, University of Western Australia, Perth, WA, Australia.; Owen RG; Haematological Malignancy Diagnostic Service, St James University Hospital, Leeds, United Kingdom.; Marlton P; Department of Haematology, Princess Alexandra Hospital and University of Queensland, Brisbane, QLD, Australia.; Wahlin BE; Department of Hematology, Karolinska Universitetssjukhuset and Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.; García-Sanz R; Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain.; McCarthy H; Department of Haematology, Royal Bournemouth and Christchurch Hospital, Bournemouth, United Kingdom.; Mulligan S; Department of Haematology, Royal North Shore Hospital, Sydney, NSW, Australia.; Tedeschi A; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Castillo JJ; Bing Center for Waldenstrom Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Czyż J; Department of Hematology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland.; Fernández De Larrea C; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Belada D; Department of Internal Medicine - Haematology, University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic.; Libby E; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Matous J; Colorado Blood Cancer Institute, Denver, CO.; Motta M; Department of Hematology, AO Spedali Civili di Brescia, Lombardia, Italy.; Siddiqi T; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.; Tani M; U.O. Ematologia, Dipartimento Oncologia e Ematologia, Ospedale Civile Santa Maria delle Croci, AUSL Ravenna, Italy.; Trněný M; Všeobecná fakultní nemocnice v Praze, Prague, Czechia.; Minnema MC; Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands.; Buske C; Comprehensive Cancer Center Ulm, Universitätsklinikum Ulm, Ulm, Baden-Württemberg, Germany.; Leblond V; Service d'Hématologie Clinique, Sorbonne University, Pitié Salpêtrière Hospital, Paris, France.; Treon SP; Bing Center for Waldenstrom Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Trotman J; Department of Hematology, Concord Repatriation General Hospital, Sydney, NSW, Australia.; Wu B; BeiGene USA, Inc, San Mateo, CA.; BeiGene Co, Ltd, Shanghai, China.; Yu Y; BeiGene USA, Inc, San Mateo, CA.; BeiGene Co, Ltd, Shanghai, China.; Shen Z; BeiGene USA, Inc, San Mateo, CA.; BeiGene Co, Ltd, Shanghai, China.; Chan WY; BeiGene USA, Inc, San Mateo, CA.; BeiGene Co, Ltd, Shanghai, China.; Schneider J; BeiGene USA, Inc, San Mateo, CA.; BeiGene Co, Ltd, Shanghai, China.; Allewelt H; BeiGene USA, Inc, San Mateo, CA.; BeiGene Co, Ltd, Shanghai, China.; Cohen A; BeiGene USA, Inc, San Mateo, CA.; BeiGene Co, Ltd, Shanghai, China.; Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Zhu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Wang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Guangdong Provincial Key Laboratory of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangdong, China.; Zhao JJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Calimeri T; Department of Experimental and Clinical Medicine, Magna Graecia University and Cancer Center, Catanzaro, Italy.; Meng J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Fourth Affiliated Hospital of Harbin Medical University, Heilongjiang, China.; Hideshima T; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Fulciniti M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Kang Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.; Ficarro SB; Department of Cancer Biology and Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.; Tai YT; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Hunter Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; McMilin D; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Tong H; Department of Cancer Biology and Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Mitsiades CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Treon SP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Dorfman DM; Department of Pathology, Brigham & Women's Hospital, Boston, Massachusetts, USA.; Pinkus G; Department of Pathology, Brigham & Women's Hospital, Boston, Massachusetts, USA.; Munshi NC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Tassone P; Department of Experimental and Clinical Medicine, Magna Graecia University and Cancer Center, Catanzaro, Italy.; Marto JA; Department of Cancer Biology and Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.; Anderson KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Carrasco RD; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. ruben_carrasco@dfci.harvard.edu.; Department of Pathology, Brigham & Women's Hospital, Boston, Massachusetts, USA. ruben_carrasco@dfci.harvard.edu.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: PubMed not MEDLINE; MEDLINE
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Lantermans HC; Department of Pathology, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Amsterdam, The Netherlands.; Cancer Center Amsterdam (CCA), Cancer Biology and Immunology - Target & Therapy Discovery, Amsterdam, The Netherlands.; Ma F; Department of Pathology, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Amsterdam, The Netherlands.; Cancer Center Amsterdam (CCA), Cancer Biology and Immunology - Target & Therapy Discovery, Amsterdam, The Netherlands.; Kuil A; Department of Pathology, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Amsterdam, The Netherlands.; Cancer Center Amsterdam (CCA), Cancer Biology and Immunology - Target & Therapy Discovery, Amsterdam, The Netherlands.; van Kesteren S; Department of Pathology, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Amsterdam, The Netherlands.; Cancer Center Amsterdam (CCA), Cancer Biology and Immunology - Target & Therapy Discovery, Amsterdam, The Netherlands.; Yasinoglu S; Department of Pathology, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Amsterdam, The Netherlands.; Cancer Center Amsterdam (CCA), Cancer Biology and Immunology - Target & Therapy Discovery, Amsterdam, The Netherlands.; Yang G; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Blueprint Medicines, Cambridge, MA, USA.; Buhrlage SJ; Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Wang J; Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Gray NS; Department of Chemical and Systems Biology, ChEM-H, Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, CA, USA.; Kersten MJ; Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Treon SP; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Pals ST; Department of Pathology, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Amsterdam, The Netherlands.; Cancer Center Amsterdam (CCA), Cancer Biology and Immunology - Target & Therapy Discovery, Amsterdam, The Netherlands.; Spaargaren M; Department of Pathology, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. marcel.spaargaren@amsterdamumc.nl.; Lymphoma and Myeloma Center Amsterdam - LYMMCARE, Amsterdam, The Netherlands. marcel.spaargaren@amsterdamumc.nl.; Cancer Center Amsterdam (CCA), Cancer Biology and Immunology - Target & Therapy Discovery, Amsterdam, The Netherlands. marcel.spaargaren@amsterdamumc.nl.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Academic Journal
Castillo JJ; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Branagan AR; Department of Medicine, Harvard Medical School, Boston, MA.; Center for Multiple Myeloma, Massachusetts General Hospital, Boston, MA.; Sermer D; Department of Medicine, Harvard Medical School, Boston, MA.; Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, MA.; Flynn CA; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Meid K; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Little M; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Stockman K; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; White T; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Canning A; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Guerrera ML; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Kofides A; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Liu S; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Liu X; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Richardson K; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Tsakmaklis N; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Patterson CJ; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Hunter ZR; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Treon SP; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Sarosiek S; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Treon SP
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어